D. Strayer

发表

Clinically Relevant Subclassifying Chronic Fatigue Syndrome through Exercise Testing

J. VanNess, C. Snell, D. Strayer, 2016 .

Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

T. Ichinohe, M. Imai, M. Tashiro, 2007, The Journal of infectious diseases.

Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease.

D. Strayer, D. Gillespie, D. Shapiro, 1991, International journal of immunopharmacology.

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:PolyC12U in the treatment of HIV infection

N. Klimas, D. Strayer, W. Carter, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-α administered to the buccal mucosa

A. Osterhaus, D. Strayer, K. Stittelaar, 2014, Antiviral Research.

Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen

D. Strayer, K. Strauss, W. Mitchell, 1995 .

Cardiac Toxicity in Chronic Fatigue Syndrome: Results from a Randomized 40-Week Multicenter Double-blind Placebo Control Trial of Rintatolimod

D. Strayer, B. Stouch, W. Carter, 2010 .

Discordant Biological and Toxicological Species Responses to TLR3 Activation

D. Strayer, W. Mitchell, W. Carter, 2014, The American Journal of Pathology.

Leukocyte Interferon-α-n3 Inhibits Influenza A Viral Replication in Human Alveolar Epithelial A549 Cells.

Wenjun Ma, J. Richt, D. Strayer, 2015 .

A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

D. Strayer, Staci R. Stevens, W. Mitchell, 2012, PloS one.

Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer.

D. Strayer, E. Pequignot, I. Brodsky, 1984, Cancer Research.

Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

D. Strayer, W. Mitchell, Diane Young, 2020, PloS one.

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): Characteristics of Responders to Rintatolimod

D. Strayer, Staci R. Stevens, W. Mitchell, 2015 .

Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.

P. Goepfert, D. Strayer, E. Overton, 2014, Vaccine.

CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL EFFECTS OF AMPLIGEN, A MISMATCHED DOUBLE-STRANDED RNA, IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

D. Montefiori, D. Volsky, K. Karikó, 1987, The Lancet.

Extremely high levels of natural killer cells in angioimmunoblastic lymphadenopathy

F. Ligler, D. Strayer, H. Bonner, 1983, Journal of Clinical Immunology.

HHV-6 reactivation in chronic fatigue syndrome

A. Komaroff, S. Josephs, D. Strayer, 1991, The Lancet.

Implications of retroviral and oncogene activity in chronic myelogenous leukemia.

D. Strayer, D. Gillespie, I. Brodsky, 1987, Cancer genetics and cytogenetics.

Antiproliferative effect of mismatched double-stranded RNA on fresh human tumor cells analyzed in a clonogenic assay.

D. Strayer, P. Watson, I. Brodsky, 1986, Journal of interferon research.

Carcinoid tumor response to fibroblast interferon.

R. Curley, D. Strayer, T. Gain, 1984, JAMA.

Antiproliferative effect of natural beta interferon on fresh tumor cells analyzed in a clonogenic assay.

D. Strayer, I. Brodsky, W. Carter, 1984, Journal of interferon research.

Intranasal administration of adjuvant‐combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus

T. Ichinohe, N. Nagata, M. Tashiro, 2010, Journal of medical virology.

Integrity of parental DNA during replication.

D. Strayer, P. Boyer, 1978, Journal of molecular biology.

Platelet DNA polymerase levels in CML: implications for oncogenesis.

D. Strayer, D. Gillespie, I. Brodsky, 1984, Leukemia research.

Therapeutic Applications of Double-Stranded RNAs

J. J. Greene, D. Strayer, W. Carter, 1984 .

Growth of Astrocytomas in the Human Tumor Clonogenic Assay and Sensitivity to Mismatched dsRNA and Interferons

A. Cook, D. Strayer, W. Carter, 1987, American journal of clinical oncology.

Agents Which Modulate the Activity of Interferon

D. Strayer, W. Carter, 1984 .

Antiproliferative and immunomodulatory actions of beta-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice.

D. Strayer, W. Carter, K. Kvalnes-Krick, 1985, Cancer research.

The Nature and Organization of Retroviral Genes in Animal Cells

D. Strayer, D. Gillespie, 1980, Virology Monographs.

Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft

D. Strayer, E. Pequignot, R. Bigler, 2005, Cancer Immunology, Immunotherapy.

Clinical studies with mismatched double-stranded RNA.

J. J. Greene, D. Strayer, D. Gillespie, 1981, Texas reports on biology and medicine.

Quantitation of RNA‐dependent platelet DNA polymerase in patients with myeloproliferative disorders

D. Strayer, D. Gillespie, I. Brodsky, 1982, British journal of haematology.

MISMATCHED DOUBLE-STRANDED RNA (AMPLIGEN) REDUCES CONCENTRATION OF ZIDOVUDINE (AZIDOTHYMIDINE) REQUIRED FOR IN-VITRO INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

D. Montefiori, D. Strayer, W. Robinson, 1987, The Lancet.

Comparative studies of ampligen (mismatched double-stranded RNA) and interferons.

D. Strayer, W. Carter, L. Krueger, 1985, Journal of biological response modifiers.

Clinical studies with ampligen (mismatched double-stranded RNA).

D. Strayer, I. Brodsky, W. Carter, 1985, Journal of biological response modifiers.

Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft.

D. Strayer, E. Pequignot, W. Carter, 1987, Journal of biological response modifiers.

Specific RNA Drug Therapy of Hepatitis Viruses

D. Strayer, W. Carter, Werner Mueller, 1993, Annals of the New York Academy of Sciences.

Eosinophilic meningitis complicating Hodgkin's disease. A report of a case and review of the literature

R. Bender, D. Strayer, 1977, Cancer.

Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity

D. Strayer, I. Brodsky, W. Carter, 2005, Breast Cancer Research and Treatment.

Ebola virus disease: In vivo protection provided by the PAMP restricted TLR3 agonist rintatolimod and its mechanism of action.

D. Strayer, E. Tramontano, S. Distinto, 2023, Antiviral research.

Divergence of primate ribosomal RNA genes as assayed by restriction enzyme analysis.

B. Vogelstein, B. Nelkin, D. Strayer, 1980, Gene.

Preclinical studies with Ampligen (mismatched double-stranded RNA).

D. Strayer, I. Brodsky, W. Carter, 1985, Journal of Biological Response Modifiers.

Low NK Cell Activity in Chronic Fatigue Syndrome (CFS) and Relationship to Symptom Severity

Victoria Scott, D. Strayer, W. Carter, 2015 .

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.

M. Loveless, D. Strayer, I. Brodsky, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS).

J. VanNess, C. Snell, D. Strayer, 2005, In vivo.

Ampligen inhibits human herpesvirus-6 in vitro.

A. Komaroff, Z. Berneman, D. Strayer, 1994, In vivo.

An ancestral amplification of DNA in primates.

D. Strayer, D. Gillespie, E. Pequignot, 1980, Gene.

Subclassifying chronic fatigue syndrome through exercise testing.

J. VanNess, C. Snell, D. Strayer, 2003, Medicine and science in sports and exercise.

Physical performance and prediction of 2-5A synthetase/RNase L antiviral pathway activity in patients with chronic fatigue syndrome.

J. VanNess, C. Snell, D. Strayer, 2002, In vivo.

Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment

Wenjun Ma, J. Richt, D. Strayer, 2014, Expert review of anti-infective therapy.

Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans.

D. Strayer, W. Carter, R. Dickey, 2014, Infectious disorders drug targets.

Recombinant and natural human interferons: analysis of the incidence and clinical impact of neutralizing antibodies.

D. Strayer, W. Carter, 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.

D. Strayer, E. Pequignot, R. Williams, 1990, Anticancer research.

Origin of Retroviruses

D. Strayer, D. Gillespie, 1980 .

Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome.

P. Richman, D. Strayer, D. Strayer, 1994, Chest.

Addition of deoxynucleotides to an RNA primer by a DNA polymerase in human platelets.

D. Strayer, D. Gillespie, M. Gaspari, 1981, Biochemical and biophysical research communications.

RNA Drug Therapy Acting via the 2–5A Synthetase/RNase L Pathway

D. Strayer, D. Ablashi, W. Carter, 1993, Annals of the New York Academy of Sciences.

Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.

P. Goepfert, D. Strayer, E. Overton, 2014, Vaccine.

Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.

W. Müller, D. Strayer, H. Schröder, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intranasal administration of adjuvant‐combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus

T. Ichinohe, N. Nagata, M. Tashiro, 2010, Journal of medical virology.

Three organizations of human DNA.

R. Roeder, N. Heintz, D. Strayer, 1983, Proceedings of the National Academy of Sciences of the United States of America.